Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
about
Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent mannersClaudins--key pieces in the tight junction puzzle.Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer.Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).Serum amyloid A: a novel biomarker for endometrial cancer.Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency.Promising novel therapies for the treatment of endometrial cancerClaudin-4 expression in gastric cancer cells enhances the invasion and is associated with the increased level of matrix metalloproteinase-2 and -9 expression.Claudin7 and moesin in endometrial Adenocarcinoma; a retrospective study of 265 patients.Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.Claudins play a role in normal and tumor cell motilityDevelopment of targeted therapy in uterine serous carcinoma, a biologically aggressive variant of endometrial cancerT-DM1, a novel antibody-drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo.Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody.erbB2 Overexpression in Uterine Serous Cancer: A Molecular Target for Trastuzumab Therapy.Clostridium perfringens enterotoxin (CPE) and CPE-binding domain (c-CPE) for the detection and treatment of gynecologic cancersClostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancerLoss of Cdh1 and Trp53 in the uterus induces chronic inflammation with modification of tumor microenvironmentEndometrial serous carcinoma (uterine papillary serous carcinoma): precancerous lesions and the theoretical promise of a preventive approach.The genomics and genetics of endometrial cancer.Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer.Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro.Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.Downregulation of claudin-7 potentiates cellular proliferation and invasion in endometrial cancer.Insights into endometrial serous carcinogenesis and progression.Molecular target therapies in endometrial cancer: from the basic research to the clinic.Emerging roles of claudins in human cancerSerum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer.Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.Emerging therapeutic targets in endometrial cancer.Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.A role for fibronectin-leucine-rich transmembrane cell-surface proteins in homotypic cell adhesion.CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma.Immunophenotyping of serous carcinoma of the female genital tract.Next-Generation Sequencing.Significant common environmental effects on leukocyte subpopulations.
P2860
Q28486318-C586A14E-D2BA-42E8-A34E-D2B0E6B02E5FQ33342823-2F66BAF3-C7CB-4F60-A088-F69A80FC5910Q33405749-AF5FA25D-FF19-4B90-B7AD-5B4951061AE9Q33442189-B5CB232C-0DE2-4FE4-B1CA-70B2D4C56DBAQ33590557-7B87C4B0-59A4-4301-8B19-B45A318A1B1DQ33643221-4772D9B5-88B8-4A73-9DAF-5D7F23D45B3EQ33814933-15E74E71-C5F1-46EB-B7EF-B92DCE762F00Q33920661-8E31B90A-80E6-49B1-8F80-36CE6810259CQ33967794-92713138-3728-4A51-865C-00A88444DAE5Q34137969-DF112DD4-DF22-4D4F-83CE-C99E3629836BQ34287768-1B88A0C2-D89F-4C6B-B203-C80F2A322F53Q34632347-9CE0897D-50A8-4878-8C72-7A4BF265AB52Q34634149-8D8BA7F5-0ED3-4251-B4A8-44C54E4127C4Q34998509-4F47CE2B-C85E-4B93-B16E-7454BC74E8B8Q35083850-8FA005FB-56C8-43DE-8541-1CEDC9BF6C41Q35174196-FDB88C27-3A08-4453-8012-1D82EFD13E2EQ35564030-D3B01F63-B595-44A7-9893-3EF3525994EBQ35659378-5FC967F0-19D0-4C26-8779-C8E4DD92FD25Q36000984-5E6D3A77-63DA-466D-A506-5052BE36DD55Q36003197-8C80BCCC-5D5C-45CD-94BB-EE027C37B45EQ36151896-8B6A5018-FFC5-469C-98CD-8BF7290424AFQ36244220-262AB9BF-D3D8-4865-850E-010E747CDA74Q36421292-F293C132-BD3F-4D28-9FE1-ABE9F0BAA54CQ36983909-25FF0F1E-020C-45A9-AC2A-01437C181556Q37092609-7C694DAC-A305-47D9-9C1A-6E34AED9100FQ37127024-8F2A9DA9-FFCF-4251-B5F6-83BB8B8E9945Q37196543-39D42179-6F7E-4B63-888A-5D2D7E4A72EBQ37225107-9D5A9A96-7A99-4679-A9B1-A904E0A93EABQ37287461-D9058149-B2E3-47DD-A009-8BAD53B89AFCQ37684642-C9B29B52-ABAA-413C-BF3D-DE8B0553866CQ37827340-6D4F6240-B947-4988-813D-7E6306456224Q38264390-92906A33-05C2-400E-BF5C-EF9CBFD1255EQ40324374-F4EA650F-E6FD-4C04-AFDA-4DC169EB6A3CQ42011951-E4226627-59EB-4DEE-857A-F8C38FD813F8Q43997124-E03424CE-FFA8-4AE9-A087-E9B6809FDAACQ51032285-F2C60235-29ED-4CA9-8F08-B0EF934F02AAQ55098865-D643CB17-9404-452A-AF77-13F00BDCA48C
P2860
Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Gene expression fingerprint of ...... s cancer diagnosis and therapy
@ast
Gene expression fingerprint of ...... s cancer diagnosis and therapy
@en
type
label
Gene expression fingerprint of ...... s cancer diagnosis and therapy
@ast
Gene expression fingerprint of ...... s cancer diagnosis and therapy
@en
prefLabel
Gene expression fingerprint of ...... s cancer diagnosis and therapy
@ast
Gene expression fingerprint of ...... s cancer diagnosis and therapy
@en
P2093
P2860
P356
P1476
Gene expression fingerprint of ...... s cancer diagnosis and therapy
@en
P2093
A D Santin
J Shaughnessy
M J Cannon
M Palmieri
S Pecorelli
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602480
P407
P577
2005-04-01T00:00:00Z